These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10818670)

  • 1. Influenza virus sialidase: a target for drug discovery.
    Kiefel MJ; von Itzstein M
    Prog Med Chem; 1999; 36():1-28. PubMed ID: 10818670
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuraminidase inhibitors as potential anti-influenza drugs.
    Bamford MJ
    J Enzyme Inhib; 1996; 10(1):1-16. PubMed ID: 8835926
    [No Abstract]   [Full Text] [Related]  

  • 3. Relenza.
    McCauley J
    Curr Biol; 1999 Nov; 9(21):R796. PubMed ID: 10556097
    [No Abstract]   [Full Text] [Related]  

  • 4. Resistance of influenza viruses to neuraminidase inhibitors--a review.
    McKimm-Breschkin JL
    Antiviral Res; 2000 Jul; 47(1):1-17. PubMed ID: 10930642
    [No Abstract]   [Full Text] [Related]  

  • 5. The synthesis of 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid: a potent influenza virus sialidase inhibitor.
    von Itzstein M; Wu WY; Jin B
    Carbohydr Res; 1994 Jun; 259(2):301-5. PubMed ID: 8050102
    [No Abstract]   [Full Text] [Related]  

  • 6. Disarming flu viruses.
    Laver WG; Bischofberger N; Webster RG
    Sci Am; 1999 Jan; 280(1):78-87. PubMed ID: 9891421
    [No Abstract]   [Full Text] [Related]  

  • 7. Position statement: global neuraminidase inhibitor susceptibility network.
    Zambon M; Hayden FG;
    Antiviral Res; 2001 Mar; 49(3):147-56. PubMed ID: 11428241
    [No Abstract]   [Full Text] [Related]  

  • 8. Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase.
    Watson KG; Cameron R; Fenton RJ; Gower D; Hamilton S; Jin B; Krippner GY; Luttick A; McConnell D; MacDonald SJ; Mason AM; Nguyen V; Tucker SP; Wu WY
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1589-92. PubMed ID: 15006410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the availability of a neuraminidase inhibitor impair influenza vaccination? A report from Austria.
    Kunze U; Groman E; Vymazal K; Hartl HK
    Vaccine; 2001 Feb; 19(15-16):1854. PubMed ID: 11345055
    [No Abstract]   [Full Text] [Related]  

  • 10. Zanamivir. A potent and selective inhibitor of influenza A and B viruses.
    Aoki FY; Hayden FG
    Clin Pharmacokinet; 1999; 36 Suppl 1():v-ix. PubMed ID: 10429834
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis of 6-acetamido-5-amino- and -5-guanidino-3, 4-dehydro-N-(2-ethylbutyryl)- 3-piperidinecarboxylic acids related to zanamivir and oseltamivir, inhibitors of influenza virus neuraminidases.
    Shitara E; Nishimura Y; Nerome K; Hiramoto Y; Takeuchi T
    Org Lett; 2000 Nov; 2(24):3837-40. PubMed ID: 11101432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuraminidase inhibitors as antivirals.
    Colman PM
    Vaccine; 2002 May; 20 Suppl 2():S55-8. PubMed ID: 12110259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zanamivir: from drug design to the clinic.
    Elliott M
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1885-93. PubMed ID: 11779388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors.
    Mishin VP; Novikov D; Hayden FG; Gubareva LV
    J Virol; 2005 Oct; 79(19):12416-24. PubMed ID: 16160169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir.
    Bantia S; Parker CD; Ananth SL; Horn LL; Andries K; Chand P; Kotian PL; Dehghani A; El-Kattan Y; Lin T; Hutchison TL; Montgomery JA; Kellog DL; Babu YS
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1162-7. PubMed ID: 11257030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and influenza virus sialidase inhibitory activity of analogues of 4-Guanidino-Neu5Ac2en (Zanamivir) modified in the glycerol side-chain.
    Andrews DM; Cherry PC; Humber DC; Jones PS; Keeling SP; Martin PF; Shaw CD; Swanson S
    Eur J Med Chem; 1999; 34(7-8):563-74. PubMed ID: 11278042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuraminidase inhibitors as antiviral agents.
    Alymova IV; Taylor G; Portner A
    Curr Drug Targets Infect Disord; 2005 Dec; 5(4):401-9. PubMed ID: 16535861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides.
    Smith PW; Sollis SL; Howes PD; Cherry PC; Starkey ID; Cobley KN; Weston H; Scicinski J; Merritt A; Whittington A; Wyatt P; Taylor N; Green D; Bethell R; Madar S; Fenton RJ; Morley PJ; Pateman T; Beresford A
    J Med Chem; 1998 Mar; 41(6):787-97. PubMed ID: 9526555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimen.
    Macdonald SJ; Watson KG; Cameron R; Chalmers DK; Demaine DA; Fenton RJ; Gower D; Hamblin JN; Hamilton S; Hart GJ; Inglis GG; Jin B; Jones HT; McConnell DB; Mason AM; Nguyen V; Owens IJ; Parry N; Reece PA; Shanahan SE; Smith D; Wu WY; Tucker SP
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4542-9. PubMed ID: 15561823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA.
    Greengard O; Poltoratskaia N; Leikina E; Zimmerberg J; Moscona A
    J Virol; 2000 Dec; 74(23):11108-14. PubMed ID: 11070006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.